Back
#1
23.3%
Top 45%
15.3%
Top 24%
6.7%
Top 2%
6.2%
Top 47%
5.8%
Top 2%
2.9%
Top 8%
2.0%
Top 1%
2.0%
Top 20%
2.0%
Top 1%
2.0%
Top 9%
1.6%
Top 1%
1.6%
Top 13%
1.4%
Top 6%
1.4%
Top 49%
1.2%
Top 11%
1.0%
Top 3%
1.0%
Top 25%
0.7%
Top 25%
0.7%
Top 14%
0.7%
Top 3%
0.7%
Top 33%
0.7%
Top 1%
0.7%
Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis
2020-04-03
intensive care and critical care medicine
Title + abstract only
View on medRxiv
Show abstract
PurposeCoronaviruses may activate dysregulated host immune responses. As exploratory studies have suggested that interleukin-6 (IL-6) levels are elevated in cases of complicated COVID-19 and that the anti-IL-6 biologic tocilizumab may be beneficial, we undertook a systematic review and meta-analysis to assess the evidence in this field. MethodsWe systematically searched MEDLINE and EMBASE for studies investigating the immunological response in COVID-19 or its treatment with tocilizumab; additio...
Predicted journal destinations
1
Frontiers in Medicine
99 training papers
2
PLOS ONE
1737 training papers
3
BMJ Open
553 training papers
4
Frontiers in Immunology
140 training papers
5
Scientific Reports
701 training papers
6
European Respiratory Journal
44 training papers
7
JAMA Network Open
125 training papers
8
Critical Care Explorations
15 training papers
9
eLife
262 training papers
10
BMJ
49 training papers
11
The Journal of Infectious Diseases
137 training papers
12
New England Journal of Medicine
49 training papers
13
Journal of Clinical Medicine
77 training papers
14
iScience
74 training papers
15
Nature Communications
483 training papers
16
Journal of Medical Virology
95 training papers
17
eClinicalMedicine
55 training papers
18
Clinical Infectious Diseases
219 training papers
19
BMC Infectious Diseases
110 training papers
20
Vaccines
131 training papers
21
Trials
24 training papers
22
BMC Medicine
155 training papers
23
Clinical Pharmacology & Therapeutics
19 training papers